Literature DB >> 28413180

Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering.

Mikio Takanashi1, Yoshino Taira1, Sachiko Okazaki1, Satoru Takase1, Takeshi Kimura1, Cheng Cheng Li1, Peng Fei Xu1, Akari Noda1, Ichiro Sakata2, Hidetoshi Kumagai3, Yuichi Ikeda3, Yoko Iizuka1, Naoya Yahagi1, Hitoshi Shimano1, Jun-Ichi Osuga4, Shun Ishibashi4, Takashi Kadowaki1, Hiroaki Okazaki1.   

Abstract

AIM: Myriad biological effects of leptin may lead to broad therapeutic applications for various metabolic diseases, including diabetes and its complications; however, in contrast to its anorexic effect, the molecular mechanisms underlying adipopenic and glucose-lowering effects of leptin have not been fully understood. Here we aim to clarify the role of hormone-sensitive lipase (HSL) in leptin's action.
METHODS: Wild-type (WT) and HSL-deficient (HSLKO) mice were made hyperleptinemic by two commonly-used methods: adenovirus-mediated overexpression of leptin and continuous subcutaneous infusion of leptin by osmotic pumps. The amount of food intake, body weights, organ weights, and parameters of glucose and lipid metabolism were measured.
RESULTS: Hyperleptinemia equally suppressed the food intake in WT and HSLKO mice. On the other hand, leptin-mediated fat loss and glucose-lowering were significantly blunted in the absence of HSL when leptin was overexpressed by recombinant adenovirus carrying leptin. By osmotic pumps, the fat-losing and glucose-lowering effects of leptin were milder due to lower levels of hyperleptinemia; although the difference between WT and HSLKO mice did not reach statistical significance, HSLKO mice had a tendency to retain more fat than WT mice in the face of hyperleptinemia.
CONCLUSIONS: We clarify for the first time the role of HSL in leptin's effect using a genetic model: leptin-promoted fat loss and glucose-lowering are at least in part mediated via HSL-mediated lipolysis. Further studies to define the pathophysiological role of adipocyte lipases in leptin action may lead to a new therapeutic approach to circumvent leptin resistance.

Entities:  

Keywords:  Hypoglycemia; Leptin; Leptin resistance; Lipase; Lipolysis

Mesh:

Substances:

Year:  2017        PMID: 28413180      PMCID: PMC5684476          DOI: 10.5551/jat.39552

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  63 in total

1.  Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.

Authors:  M S Haque; Y Minokoshi; M Hamai; M Iwai; M Horiuchi; T Shimazu
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

2.  The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity.

Authors:  Roberto Coppari; Masumi Ichinose; Charlotte E Lee; Abigail E Pullen; Christopher D Kenny; Robert A McGovern; Vinsee Tang; Shun M Liu; Thomas Ludwig; Streamson C Chua; Bradford B Lowell; Joel K Elmquist
Journal:  Cell Metab       Date:  2005-01       Impact factor: 27.287

3.  PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging.

Authors:  Dipsikha Biswas; Mainak Ghosh; Subhankar Kumar; Partha Chakrabarti
Journal:  FASEB J       Date:  2016-08-02       Impact factor: 5.191

4.  Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy.

Authors:  G Chen; K Koyama; X Yuan; Y Lee; Y T Zhou; R O'Doherty; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.

Authors:  Y Minokoshi; M S Haque; T Shimazu
Journal:  Diabetes       Date:  1999-02       Impact factor: 9.461

Review 6.  Narrative review: the role of leptin in human physiology: emerging clinical applications.

Authors:  Theodore Kelesidis; Iosif Kelesidis; Sharon Chou; Christos S Mantzoros
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  Adipose triglyceride lipase contributes to cancer-associated cachexia.

Authors:  Suman K Das; Sandra Eder; Silvia Schauer; Clemens Diwoky; Hannes Temmel; Barbara Guertl; Gregor Gorkiewicz; Kuppusamy P Tamilarasan; Pooja Kumari; Michael Trauner; Robert Zimmermann; Paul Vesely; Guenter Haemmerle; Rudolf Zechner; Gerald Hoefler
Journal:  Science       Date:  2011-06-16       Impact factor: 47.728

10.  Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARα signaling.

Authors:  Sascha Obrowsky; Prakash G Chandak; Jay V Patankar; Silvia Povoden; Stefanie Schlager; Erin E Kershaw; Juliane G Bogner-Strauss; Gerald Hoefler; Sanja Levak-Frank; Dagmar Kratky
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

View more
  3 in total

Review 1.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

2.  Leptin Resistance and Lipolysis of White Adipose Tissue: An Implication to Ectopic Fat Disposition and Its Consequences.

Authors:  Michio Shimabukuro
Journal:  J Atheroscler Thromb       Date:  2017-08-05       Impact factor: 4.928

3.  Critical Role of SREBP-1c Large-VLDL Pathway in Environment-Induced Hypertriglyceridemia of Apo AV Deficiency.

Authors:  Mikio Takanashi; Takeshi Kimura; Chengcheng Li; Masaki Tanaka; Ako Matsuhashi; Hiroki Yoshida; Akari Noda; Pengfei Xu; Satoru Takase; Sachiko Okazaki; Yoko Iizuka; Hidetoshi Kumagai; Yuichi Ikeda; Takanari Gotoda; Manabu Takahashi; Hiroaki Yagyu; Shun Ishibashi; Toshimasa Yamauchi; Takashi Kadowaki; Guosheng Liang; Hiroaki Okazaki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.